BDBM63249 (3,5-dimethyl-1-piperidinyl)-[4-[(3H-imidazo[4,5-c]pyridin-2-ylthio)methyl]phenyl]methanone::(3,5-dimethylpiperidin-1-yl)-[4-(3H-imidazo[4,5-c]pyridin-2-ylsulfanylmethyl)phenyl]methanone::(3,5-dimethylpiperidino)-[4-[(3H-imidazo[4,5-c]pyridin-2-ylthio)methyl]phenyl]methanone::2-({4-[(3,5-dimethylpiperidin-1-yl)carbonyl]benzyl}thio)-1H-imidazo[4,5-c]pyridine::MLS000586918::SMR000208848::cid_6623229

SMILES COc1cc(Nc2nc(-c3ccc4cc[nH]c4c3)cn3ncnc23)ccc1N1CCOCC1

InChI Key InChIKey=ULLZZWOHDXHGNY-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63249   

TargetTyrosine-protein kinase SYK(Human)
Nanjing Ruijie Pharma Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 63249BDBM63249(6-(1H-indol-6-yl)-N-(3-methoxy-4-morpholinophenyl)...)
Affinity DataIC50: 50nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent